Gordon M. Saul

Stanford Byers Center for Biodesign is a private company committed to advancing health outcomes and equity through innovation education, translation, and policy. More than 4.3 million people have been helped by technologies invented at Stanford Biodesign, and the biodesign innovation process has been widely adopted by universities and training programs around the world. The American company believes that diversity across multiple dimensions inspires creativity and helps them innovate for all patient populations. The company was founded by Joshua Makower and Paul G. Yock in 2001 at Stanford.

Stanford Byers Center for Biodesign is a private company committed to advancing health outcomes and equity through innovation education, translation, and policy. More than 4.3 million people have been helped by technologies invented at Stanford Biodesign, and the biodesign innovation process has been widely adopted by universities and training programs around the world. The American company believes that diversity across multiple dimensions inspires creativity and helps them innovate for all patient populations. The company was founded by Joshua Makower and Paul G. Yock in 2001 at Stanford.

Stanford Byers Center for Biodesign is a private company committed to advancing health outcomes and equity through innovation education, translation, and policy. More than 4.3 million people have been helped by technologies invented at Stanford Biodesign, and the biodesign innovation process has been widely adopted by universities and training programs around the world. The American company believes that diversity across multiple dimensions inspires creativity and helps them innovate for all patient populations. The company was founded by Joshua Makower and Paul G. Yock in 2001 at Stanford.

Stanford Byers Center for Biodesign is a private company committed to advancing health outcomes and equity through innovation education, translation, and policy. More than 4.3 million people have been helped by technologies invented at Stanford Biodesign, and the biodesign innovation process has been widely adopted by universities and training programs around the world. The American company believes that diversity across multiple dimensions inspires creativity and helps them innovate for all patient populations. The company was founded by Joshua Makower and Paul G. Yock in 2001 at Stanford.

Stanford Byers Center for Biodesign is a private company committed to advancing health outcomes and equity through innovation education, translation, and policy. More than 4.3 million people have been helped by technologies invented at Stanford Biodesign, and the biodesign innovation process has been widely adopted by universities and training programs around the world. The American company believes that diversity across multiple dimensions inspires creativity and helps them innovate for all patient populations. The company was founded by Joshua Makower and Paul G. Yock in 2001 at Stanford.